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INTRODUCTION 
The rate of dissolution of a solid is a function of its 
solubility that influences the absorption of relatively 
insoluble drugs
1
. In general, it can be stated that the rate of 
absorption and hence the onset of action is determined by 
the dissolution of the drug and subsequent transport over 
the intestinal membrane and passage through the liver. 
According to the Biopharmaceutical Classification System 
(BCS), four different types of drug absorption regimes are 
distinguished
2
. SIM is class II drug
14
. Solubility is 
generally expressed as the number of grams of solute in 
one litre o f saturated solution 
3.
 The solute molecule is 
pulled into solution when the force overcomes the 
attractive force between the solute molecule and its 
neighboring solute molecule
4
. The positive ion of the 
solute is attracted to the negative end of the solvent 
molecule 
5
. As the particle size reduces the surface area of 
the solute particle increases and the solute dissolves more 
rapidly 
6
. pH of the medium also effect solubility of weak 
acidic and basic drugs
7
. The amorphous form of a 
compound is always more soluble than a corresponding 
crystal form 
8
. Very weakly acidic or basic drugs may 
require a pH that could fall outside the accepted tolerable 
physiological range or may cause stability problems with 
formulat ion ingredients
 9
. If a drug is poorly soluble, then 
it will only slowly dissolve, perhaps leading to incomplete 
absorption 
10, 11
. Poor aqueous solubility leads to poor 
dissolution and ultimately poor oral bioavailability 
12,23
.Many methods such as particle size reduction, solid-
dispersion, salt formation have mainly used for solubility, 
dissolution and bioavailability enhancement of poorly 
aqueous soluble drugs. All these techniques have some 
limitat ions 
13,20
. The Particle size reduction method 
produces small particles having larger surface area so 
enhance absorption and dissolution but the small particles 
having limitation for wettability and flow properties 
15
. 
Solid dispersion method having limitation because the 
method of preparation is tough 
16, 17
, change in the 
physicochemical property of   materials which is not 
reproducible 
18
; large scale manufacturing processes and 
dosage form development is very difficult 
19,24
. So, 
Physical mixture method, co-grinding method, spray 
drying method were compared for solubility enhancement 
of simvastatin as these methods requires less money. Here 
the natural polymer CHI compared with synthetic polymer 
HPMCE3LV for solubility enhancementment of SIM to 
provide cost effective formulat ion. 
MATERIAL AND METHOD 
Material  
Drug Simvastatin ,Chitosan(CHI) were procured from 
Artimis biotech, Hyderabad . Hydroxy propyl methyl 
cellu lose (HPMCE3LV) was procured from Colorcon Asia 
Ltd., Goa. All other chemicals used were of analytical 
grade. 
Drug – Excipient interaction study 
The pure drug (SIM), a mixtures of SIM with HPMCE3LV 
and SIM with chitosan(CHI) are mixed separately with IR 
grade KBr in the rat io of 100:1. The pellets were then 
scanned over a wave range of 4000-400cm
-1 
in FTIR 
instrument.  
Preparation of physical mixture
21
  
Physical mixture o f drug and polymers were prepared in  
different ratio such as 1:1 to 1:9 w/w. Simply polymer and 
drug were taken in polyethylene bag and bag was 
thoroughly vibrated by hand for proper mixing
21
. 
Preparation of co-grinding mixture 
22 
Co-grinded mixture of drug and polymers were prepared in  
different ratio such as 1:1 to 1:9 w/w. It was co-grinded for 
5min, in ceramic mortar and sieved through 100 # mesh. 
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Co-solvent evaporation method -S pray drying
 21
 
The solvent evaporation of SIM with Chitosan solution in 
ratio (1:1, 1:2, 1:6, 1:9 w/w) was carried out by using 
spray dryer (LU-222, Advanced, Labult ima, India). The 
solutions prepare by dissolving 1g of drug in 40 ml of 
methanol and 1g of Chitosan in 1% acet ic acid and mixed  
both solutions which produces clear solution. The solvent 
evaporated at inlet 120 
o
C and outlet 80 
o
C , feed pump 
speed 10 ml per minute and aspiration 45 %.  
The solvent evaporation of SIM with  
HPMCE3LVsolution in ratio (1:1, 1:2, 1:6, 1:9 w/w) was 
carried out by using spray dryer (LU-222, Advanced, 
Labult ima, India). The solutions prepare by dissolving 1g 
of drug in 70 ml of methanol and 1g of HPMCE3LVin 30 
ml of distilled water and mixed both solutions which 
produces clear solution. The solvent evaporated at inlet 
120
o
C and outlet 80
o
C, feed pump speed 10 ml per minute 
and aspiration 45 %.  
Solubility study 
The solubility was determined in pH 1.2 HCl buffer, and 7 
pH buffer.  The solubility of drug, and mixture were 
determined by taking an excess amount 30 mg of drug and 
added them in 10 ml of above solvents, in teflon facing 
screw capped vials. The samples were kept at equilibrium 
for a period of 48 hr on orbital shaking incubator at 37 ± 
0.5
o
C and 50 rpm. The content of vials were filtered  
through 0.2 micron filter, and analyzed by UV-Vis ible 
spectrophotometer at 238 nm. 
Differential Scanning Calorimetry (DSC) 
Analysis of samples was carried out on DSC instruments at 
heating rate of 10 
0
C /min. The measurements were 
performed at a heating range of 10 to 350 
0
C under 
nitrogen pressure. 
X-Ray Diffraction studies (XRD) 
 X-ray diffract ion patterns of samples were obtained using 
Philips diffractometer and Cu-Kα line as a source of 
radiation which was operated at the voltage 40 kV and the 
current 30 mA.  
Scanning Electron Microscopy (S EM)  
The morphology of samples was determined using 
scanning electron microscope (SEM). 
Preparation of immediate release tablet 
All co-grinded mixtures equivalent to 10 mg of SIM was 
mixed with excip ients for 10 minutes in porcelain mortar, 
passed through 60 # sieve. Th is blend was mixed with 
magnesium stearate for 5 minutes and processed for direct 
compression by using 7mm round flat - faced punch of 
rotary tablet machine (Rimek mini press -1).  
Table 1: Content of immediate release tablets (CGS CHI) cogrinding mixtures  
Component in mg F1  F2  F3  F4  
Simvastatin 10 10 10 10 
Chitosan 70 70 70 70 
Sodium Starch glycolate 7.5 7.5 9 9 
Citric acid 6 7 7 8 
Sodium Bicarbonate  30 35 35 40 
Lactose 23.5 17.5 16 10 
Talc 1.5 1.5 1.5 1.5 
Mg-stearate 1.5 1.5 1.5 1.5 
 
Table 2: Content of immediate release tablets (CGS HPMC) co-grinding mixtures  
Component in mg F1  F2  F3  F4  
Simvastatin 10 10 10 10 
HPMCE3LV 60 60 60 60 
Sodium Starch glycolate  6 6 7.5 7.5 
Citric acid 5 6 6 7 
Sodium Bicarbonate  25 30 30 35 
Lactose 41 34 32.5 26.5 
Talc 1.5 1.5 1.5 1.5 
Mg-stearate 1.5 1.5 1.5 1.5 
 
Drug content 
Simvastatin content in the methanolic extract was analyzed  
spectrophotometrically at  238 nm, against the standard 
methanolic solution of simvastatin. 
Dissolution Test 
Dissolution test of tablets were performed using pH 1.2 
HCl buffer and pH 7 buffer with USP d issolution 
apparatus II at 50 rpm and 37 ± 0.5 
0
C. Test samples (5 ml) 
were withdrawn at particular time interval (5, 10, 15, 20 
and 30 minutes) and replaced with fresh dissolution media 
maintained at 37 ± 0.5 
0
C. The test samples were filtered  
and the concentration of dissolved drug was determined 
using UV spectrophotometer at λmax 238 nm.  
Stability Study 
The accelerated stability study of co-grinding mixture 
tablet was checked for stability as per ICH guidelines at 40 
0
C/75% RH up to 3 months. 
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RES ULT AND DISCUSSION 
HPMC having surfactant activity 
1
which reduces the 
contact angle and increases wetting of drug particles, thus 
enhance the solubilisation and dissolution of drug 
particles. It is reported that the swelling of polymers 
influences improvement of dissolution rate of poorly 
aqueous soluble drugs 
2
.So preferred less swelling and less 
viscosity polymers. Due to the less toxic effect, 
biodegradable nature and low production cost these 
polymers mainly used as drug carrier in Pharmaceutical 
industry.  
Drug- Excipient Interaction 
Drug-excipient interaction checked using FTIR 
spectrophotometer. The characteristic peaks found in SIM. 
These peaks also found in drug-polymer mixture, which  
indicates no drug-excipient interaction. 
Table 3: Physical Mixing of Drug with Chitosan 
Ratio Absorbance Solubility(mg/ml) Native Solubility(mg/ml) Increment 
 pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  
1:1 0.056 0.45 0.0860 0.55 0.0418 0.457 2.057 1.25 
1:2 0.059 0.48 0.092 0.6 0.0418 0.457 2.200 1.363 
1:3 0.067 0.54 0.1083 0.685 0.0418 0.457 2.590 1.556 
1:4 0.074 0.66 0.1222 0.857 0.0418 0.457 2.923 1.947 
1:5 0.086 0.68 0.1461 0.885 0.0418 0.457 3.495 2.011 
1:6 0.097 0.98 0.1643 1.31 0.0418 0.457 3.930 2.977 
1:7 0.076 0.63 0.1254 0.871 0.0418 0.457 3 1.90 
1:8 0.049 0.59 0.072 0.81 0.0418 0.457 1.735 1.77 
1:9 0.045 0.39 0.064 0.504 0.0418 0.457 1.54 1.104 
 
Table 4: Co-grinding of Drug with Chitosan 
Ratio Absorbance Solubility(mg/ml) Native Solubility(mg/ml) Increment 
 pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  
1:1 0.057 0.412 0.088 0.502 0.0418 0.4571 2.10 1.098 
1:2 0.067 0.424 0.1083 0.520 0.0418 0.4571 2.59 1.13 
1:3 0.089 0.449 0.1520 0.555 0.0418 0.4571 3.63 1.21 
1:4 0.091 0.550 0.1536 0.7 0.0418 0.4571 3.67 1.53 
1:5 0.095 0.625 0.1640 1.21 0.0418 0.4571 3.93 2.64 
1:6 0.099 0.511 0.1719 0.644 0.0418 0.4571 4.11 1.40 
1:7 0.219 0.984 0.410 1.412 0.0418 0.4571 9.82 3.091 
1:8 0.079 0.320 0.1322 0.3714 0.0418 0.4571 3.16 0.81 
1:9 0.068 0.319 0.1103 0.370 0.0418 0.4571 2.63 0.80 
 
Table 5: S pray drying with chitosan  
Ratio Absorbance Solubility(mg/ml) Native solubility Increment 
 pH1.2 pH7 pH1.2 pH7 pH1.2 pH 7  pH1.2 pH 7  
1:1 0.051 0.419 0.0765 0.5134 0.041 0.457 1.830 1.123 
1:2 0.054 0.445 0.082 0.5508 0.041 0.457 1.961 1.205 
1:6 0.076 0.831 0.1262 1.11 0.041 0.457 3.019 2.428 
1:9 0.049 0.327 0.072 0.3822 0.041 0.457 1.722 0.836 
 
Table 6: Physical Mixing of Drug with HPMCE3LV  
Ratio Absorbance Solubility(mg/ml) Native Solubility(mg/ml) Increment 
 pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  
1:1 0.061 0.395 0.096 0.478 0.0418 0.4571 2.296 1.045 
1:2 0.065 0.401 0.1043 0.4871 0.0418 0.4571 2.495 1.065 
1:3 0.083 0.578 0.1401 0.74 0.0418 0.4571 3.351 1.618 
1:4 0.095 0.502 0.1640 0.6328 0.0418 0.4571 3.923 1.384 
1:5 0.103 0.475 0.1799 0.592 0.0418 0.4571 4.303 1.295 
1:6 0.121 0.893 0.2157 1.273 0.0418 0.4571 5.160 2.787 
1:7 0.081 0.512 0.1361 0.6457 0.0418 0.4571 3.255 1.412 
1:8 0.071 0.504 0.1163 0.6342 0.0418 0.4571 2.782 1.387 
1:9 0.053 0.486 0.080 0.6085 0.0418 0.4571 1.913 1.331 
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Table 7: Co-grinding of Drug with HPMCE3LV 
Ratio Absorbance Solubility(mg/ml) Native Solubility(mg/ml) Increment 
 pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  pH 1.2  pH 7  
1:1 0.049 0.39 0.072 0.471 0.041 0.457 1.735 1.031 
1:2 0.057 0.44 0.088 0.542 0.041 0.457 2.116 1.187 
1:3 0.063 0.51 0.100 0.642 0.041 0.457 2.401 1.406 
1:4 0.069 0.59 0.112 0.757 0.041 0.457 2.687 1.656 
1:5 0.079 0.65 0.132 0.842 0.041 0.457 3.162 1.844 
1:6 0.089 0.89 0.152 1.185 0.041 0.457 3.638 2.594 
1:7 0.069 0.59 0.112 0.757 0.041 0.457 2.687 1.656 
1:8 0.053 0.54 0.080 0.685 0.041 0.457 1.926 1.500 
1:9 0.049 0.47 0.072 0.585 0.041 0.457 1.735 1.281 
 
Solubility data for SIM, PMSCHI (Physical mixture of 
SIM and CHI), CGSCHI (Co grounded mixture of SIM 
and CHI),SDSCHI (Spray dried mixture of SIM and CHI), 
in different solvents are given in Table 3,4,5. ANOVA 
(P<0.001) performed on solubility parameter demonstrated 
significant difference between solubility of SIM with co-
grinded mixtures. Solubility data of PMSCHI, SDSCHI 
shows that ratio 1:6 and CGSCHI  shows that ratio 1:7 
shows highest solubility. Hence co-grinding mixture is 
optimized for further processing. 
Table 8: S pray drying with HPMCE3LV 
Ratio Absorbance Solubility(mg/ml) Native solubility Increment 
 pH1.2 pH7 pH1.2 pH7 pH1.2 pH 7  pH1.2 pH 7  
1:1 0.049 0.361 0.072 0.4302 0.041 0.457 1.722 0.941 
1:2 0.055 0.429 0.084 0.5282 0.041 0.457 2.009 1.155 
1:6 0.069 0.812 0.1123 1.07 0.041 0.457 2.686 2.341 
1:9 0.052 0.493 0.078 0.6122 0.041 0.457 1.866 1.339 
 
Solubility data for SIM, PMSHPMC (Physical mixture of 
SIM and HPMC), CGSHPMC (Co grounded mixture of 
SIM and HPMC), SDSHPMC (Spray dried mixture of SIM 
and HPMC),  in different solvents  are given in Table 6,7,8. 
ANOVA (P<0.001) performed on solubility parameter 
demonstrated significant difference between solubility of 
SIM with co-grinded mixtures. Solubility data of 
PMSHPMC, CGSHPMC, SDSHPMC shows that ratio 1:6 
shows highest solubility. Hence co-grinding mixture is 
optimized for further processing as it shows good 
solubility enhancement.   
Differential Scanning Calorimetry (DSC) 
Results of DSC studies are given in fo llowing figures.  
 
Figure 1: DSC thermogram of S IM, CHI, CGSCHI  
SIM was characterised by sharp melting endothermic peak 
at 140.63
0
C.CHI shows broad endothermic peak at 90.08 
0
C .CGSCHIshows less intensity of the peak which 
indicate the conversion of crystalline SIM to amorphous. 
SIM was characterised by sharp melting endothermic peak 
at 140.63 
0
C. HPMC shows broad endothermic peak at  
71.97 
0
C. CGSHPMC shows less intensity of the peak 
which indicate the conversion of crystalline SIM to 
amorphous. 
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Figure 2: DSC thermogram of S IM, HPMC and CGS HPMC  
X-ray Diffraction Studies (XRD) 
The X-ray diffraction patterns of drug and polymers are g iven in fo llowing figures. 
 
Figure 3: the X-ray diffraction patterns of Simvastatin 
 
0
100
200
300
400
500
600
700
0 20 40 60 80 100
 
Figure 4: the X-ray diffraction patterns of CHI 
 
Figure 5: the X-ray diffraction patterns of CGSCHI  
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Figure 6.The X-ray di ffraction patterns of 
HPMCE3LV 
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Figure 7:  The X-ray diffraction patterns of 
CGS HPMC 
The characteristic peaks in X-RD indicate the crystalline 
nature of SIM.X-R of CGSCHI, CGSHPMC shows 
absence of some characteristic peaks of SIM. Intensity of 
peaks in co-grinded indicates conversion of crystalline to 
amorphous. 
Scanning Electron Microscopy (S EM) 
The morphological characteristic of drug and processed 
drug polymer complex was shown in fo llowing figures. 
 
Figure 8: S EM of S IM 
 
Figure 9: S EM of CHI 
 
Figure 10: S EM of CGSCHI  
 
Figure 11: S EM of HPMCE3LV 
 
Figure 12: S EM of CGS HPMC 
This data further conformed by morphological 
characterisation of SIM, CHI, CGSCHI HPMCE3LV, 
CGSHPMC. SIM particles appeared as plate like crystals 
(100μm) with smooth surfaces where as chitosan appeared 
as flake like particles, HPMC consisted of amorphous 
particles of rather irregular size and shape. Crystals of SIM 
was co-grinded with polymer, it seemed that morphology 
of SIM was changed in co-grinded mixtures. 
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Evaluation of formulation    
Table 9: Pre Compression parameter of SIM-CHI immediate release tablet 
Batch Angle of 
Repose 
LBD 
(g/mL) 
TBD 
(g/mL) 
Carr’s 
Index (%) 
Hausners 
Ratio 
F1 33.23 0.52 0.64 18.40 1.23 
F2 32.58 0.47 0.53 17.32 1.12 
F3 31.71 0.52 0.60 19.33 1.15 
F4 34.47 0.49 0.57 15.03 1.16 
 
Table 10: Pre Compression parameter of S IM-HPMC immediate release tablet  
Batch Angle of 
Repose 
LBD 
(g/mL) 
TBD 
(g/mL) 
Carr’s 
Index (%) 
Hausners 
Ratio 
F1 35.74 0.52 0.64 17.89 1.19 
F2 33.56 0.47 0.53 18.11 1.26 
F3 36.24 0.52 0.60 19.50 1.30 
F4 35.08 0.49 0.57 16.23 1.23 
 
Table 11: Evaluation of S IM-CHI cogrinding Immediate release Tablet  
Properties F1 F2 F3 F4 
Weight (mg) Mean ± SD 151 ± 1.3 148 ± 0.8 146 ± 0.6 149 ± 1.4 
Hardness (kg/cm
2
) 2- 3 2-3 2-3 2-3 
Thickness (mm) Mean ± SD 1.98 ± 0.08 2.05 ± 0.07 2.12 ± .07 2.31 ± .05 
Friability (%) 0.58 0.54 0.68 0.62 
Drug content (%) Mean ± SD 98.6 ± 0.8 99.2 ± 1.3 102 ± 0.8 96 ± 1.4 
Disintegration time (Sec) 120 ± 23 152 ± 31 102 ± 16 84 ± 23 
Wetting time (seconds) 410 ± 24 340 ± 62 510 ± 27 311 ± 42 
 
Table 12: Evaluation of S IM-HPMC cogrinding Immediate release Tablet 
Properties F1  F2  F3  F4  
Weight (mg)    Mean ± SD 149± 0.88 150 ± 0.67 148 ± 0.58 149 ± 1.8 
Hardness (kg/cm
2
) 2- 3 2-3 2-3 2-3 
Thickness (mm)    Mean ± S D 2.06 ± 0.07 2.09 ± 0.03 2.11 ± 0.04 2.29± 0.03 
Friability (% ) 0.69 0.57 0.78 0.86 
Drug content (% ) Mean ± SD 99.5± 0.5 100.2 ± 2.5 100 ± 1.2 98± 2.10 
Disintegration time (Sec) 180 ± 28 195 ± 32 205± 25 170± 11 
Wetting time (seconds) 480 ± 45 420 ± 58 510 ± 64 380 ± 54 
 
Dissolution efficiency (DE) 
The dissolution profile of tablets in 1.2 pH HCl buffer and 
7 pH buffer are g iven in Tab le. The d issolution of co-
grinded mixture tablets were compared to that of marketed 
tablet (MKT) and SIM. Dissolution efficiency was 
calculated by using software PCP-Disso-v3. ANOVA 
performed on the dissolution efficiency (DE) of SIM, 
marketed tablet. Significant difference was found between 
co-grinded mixture tablets (F4), marketed tablet and SIM. 
This indicates, the dissolution rate of SIM improved in  
presence of CHI,HPMC. Tablets of CGSCHI,CGSHPMC 
have shown better solubility and dissolution enhancement.  
Table 13: DE of S IM and various cogrinded (Mean ± S.D), n= 3  
Product  1.2  pH HCL buffer 7 pH  buffer 
 DE10 DE30 DE10 DE30 
SIM 18.12 ± 0.72 25.94± 0.38 26.22 ± 0.90 51.66 ± 0.69 
MKT 24.91± 1.38 30.51± 1.02 20.94± 4.68 29.25± 0.41 
CGSCHI  (F1) 35.82± 0.99 57.98± 0.79 20.01± 0.99 39.00± 0.79 
CGSCHI  (F2) 37.90± 1.59 59.52± 1.09 20.97± 1.59 40.09± 1.09 
CGSCHI  (F3) 40.25± 3.64 61.89± 4.98 21.46± 3.64 41.83± 4.97 
CGSCHI  (F4) 41.55± 0.52 64.64± 0.36 22.21± 1.49 45.92± 0.39 
CGSHPMC(F5) 34.73± 0.55 55.84± 0.98 19.67± 0.66 38.67± 1.68 
CGSHPMC(F6) 36.69± 1.17 58.06± 1.22 21.49± 3.71 40.00± 2.28 
CGSHPMC(F7) 39.43± 4.36  61.04±0.76 22.18± 4.36 41.04± 1.62 
CGSHPMC(F8) 40.99± 4.39 63.86 ± 1.60 22.90± 0.43 45.16 ± 0.55 
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Stability Study 
Accelerated stability studies were performed at 40 
0
C/75% 
RH as per the ICH guidelines. Based on the results of 
initial characterization CGSCHI (F4), CGSHPMC (F8) are 
thought to be the superior fo rmulat ion and hence further 
subjected to accelerated stability study. There was 
insignificant decrease in dissolution rate of SIM over the 
period of 3 months. Dissolution profile (DE30) of 
optimized batches before and after stability is given in 
Table.  
Table 14: DE30 of CGSCHI tablets before and after stability (mean ± S.D), n = 3.  
 BEFORE S TABILITY AFTER STABILITY 
BATCH 1.2 pH buffer  7 pH buffer  1.2 pH buffer  7 pH buffer  
CGSCHI (F4) 64.64± 0.36 45.92± 0.39 63.86± 0.54 46.34± 0.68 
CGS HPMC(F8) 63.86± 1.60 45.16±0.55 61.08± 0.89 44.93± 0.17 
 
CONCLUS ION 
The present work successfully demonstrated the use of 
CHI and HPMCE3LV, a low viscosity grade of HPMC 
polymers as solubility enhancing material. Solubility 
enhancing properties of CHI and HPMCE3LV were 
established by solubility studies and confirmed with 
dissolution studies. Characterization of solid mixtures of 
drug with polymer such as DSC, XRD and SEM studies 
supported the results. The crystalline state of the drug was 
converted successfully into amorphous state by physical 
mixing, co-grinding and sprays drying the drug with 
polymer. But co-grinding shows the best solubility 
enhancing capacity. CHI shows better solubility 
enhancement as compare to HPMCE3LV.The natural 
polymers having surfactant activity that enhances the 
solubility and dissolution rate of drug. This natural 
polymers having advantage over other synthetic polymeras 
this polymers are biocompatible, biodegradable and having 
low cost.   
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